365 related articles for article (PubMed ID: 21677875)
1. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
2. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
3. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
[TBL] [Abstract][Full Text] [Related]
4. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.
Reeves KJ; Hurrell JE; Cecchini M; van der Pluijm G; Down JM; Eaton CL; Hamdy F; Clement-Lacroix P; Brown NJ
Int J Cancer; 2015 Apr; 136(7):1731-40. PubMed ID: 25156971
[TBL] [Abstract][Full Text] [Related]
6. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
8. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
Huang S; He P; Peng X; Li J; Xu D; Tang Y
Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
[TBL] [Abstract][Full Text] [Related]
10. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
[TBL] [Abstract][Full Text] [Related]
12. The role of S100A4 for bone metastasis in prostate cancer cells.
Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
[TBL] [Abstract][Full Text] [Related]
13. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
14. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
[TBL] [Abstract][Full Text] [Related]
15. The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.
van de Merbel AF; van Hooij O; van der Horst G; van Rijt-van de Westerlo CCM; van der Mark MH; Cheung H; Kroon J; Verhaegh GW; Tijhuis J; Wellink A; Maas P; Viëtor H; Schalken JA; van der Pluijm G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567533
[TBL] [Abstract][Full Text] [Related]
16. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
17. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
18. A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer.
Shang Z; Cai Q; Zhang M; Zhu S; Ma Y; Sun L; Jiang N; Tian J; Niu X; Chen J; Sun Y; Niu Y
Oncotarget; 2015 Jan; 6(2):1202-16. PubMed ID: 25483103
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.
Nemeth JA; Cher ML; Zhou Z; Mullins C; Bhagat S; Trikha M
Clin Exp Metastasis; 2003; 20(5):413-20. PubMed ID: 14524530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
